Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Paton

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Microbiology|July 17, 1998
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolatesJ M Bell, J C Paton, J Turnidge
Microbial Pathogenesis|January 1, 1988
Purification and immunological characterization of neuraminidase produced by Streptococcus pneumoniaeR A Lock, J C Paton, D Hansman
Microbial Pathogenesis|February 1, 1992
Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniaeR A Lock, D Hansman, J C Paton
Infection and Immunity|February 17, 2001
Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraoseA W Paton, R Morona, J C Paton
Microbial Pathogenesis|December 1, 1988
Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniaeR A Lock, J C Paton, D Hansman
Infection and Immunity|March 1, 1984
Activation of human complement by the pneumococcal toxin pneumolysinJ C Paton, B Rowan-Kelly, A Ferrante
Journal of Bacteriology|August 1, 1997
Molecular and genetic characterization of the capsule biosynthesis locus of Streptococcus pneumoniae type 19BJ K Morona, R Morona, J C Paton
Gene|February 3, 1995
Heterogeneity of the amino-acid sequences of Escherichia coli Shiga-like toxin type-I operonsA W Paton, L Beutin, J C Paton
Molecular Microbiology|February 1, 1997
Characterization of the locus encoding the Streptococcus pneumoniae type 19F capsular polysaccharide biosynthetic pathwayJ K Morona, R Morona, J C Paton
Nature Medicine|March 4, 2000
A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humansA W Paton, R Morona, J C Paton
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Microbiology|July 17, 1998
Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolatesJ M Bell, J C Paton, J Turnidge
Microbial Pathogenesis|January 1, 1988
Purification and immunological characterization of neuraminidase produced by Streptococcus pneumoniaeR A Lock, J C Paton, D Hansman
Microbial Pathogenesis|February 1, 1992
Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniaeR A Lock, D Hansman, J C Paton
Infection and Immunity|February 17, 2001
Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraoseA W Paton, R Morona, J C Paton
Microbial Pathogenesis|December 1, 1988
Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniaeR A Lock, J C Paton, D Hansman
Infection and Immunity|March 1, 1984
Activation of human complement by the pneumococcal toxin pneumolysinJ C Paton, B Rowan-Kelly, A Ferrante
Journal of Bacteriology|August 1, 1997
Molecular and genetic characterization of the capsule biosynthesis locus of Streptococcus pneumoniae type 19BJ K Morona, R Morona, J C Paton
Gene|February 3, 1995
Heterogeneity of the amino-acid sequences of Escherichia coli Shiga-like toxin type-I operonsA W Paton, L Beutin, J C Paton
Molecular Microbiology|February 1, 1997
Characterization of the locus encoding the Streptococcus pneumoniae type 19F capsular polysaccharide biosynthetic pathwayJ K Morona, R Morona, J C Paton
Nature Medicine|March 4, 2000
A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humansA W Paton, R Morona, J C Paton
Pageof 12